Latest acquisitions in the Medical Devices market

Integral service around a transaction
BY : Diego GutiérrezOctober Fri, 2020

The market for medical devices is a mature market: the acquisitionsemissions increased significantly in 2014 and indicate that they will continue to grow in 2019 and beyond. 

Baker Tilly analyses which are the most important acquisitions in the market. But first, the sector is explained. Medical devices refers to any instrument, apparatus, appliance, implement, machine, implant... Medical devices are essential for the safe and effective prevention, diagnosis, treatment and rehabilitation of disease and illness. 

Johnson & Johnson and Auris Health  

Latest acquisitions in the Medical Devices market

Multinational Johnson & Johnson has reached an agreement to buy Auris Health for $3.4 billion with the aim of accelerating its entry into robotics, simplifying surgery, boosting efficiency, reducing complications and improving patient outcomes.

Auris Health is a technology developer specialising in lung cancer treatment, as part of its creation of a digitally connected ecosystem in the healthcare sector and also positions itself as a leader in surgical procedures. 

Johnson & Johnson is an American multinational manufacturer of medical devices, pharmaceuticals, personal care, fragrances and baby products founded in 1886. 

Siemens Healthineers and Corindus 

Siemens Healthineers and Corindus 

Siemens Healthineers has signed a merger agreement with the American company Corindus Vascular Robotics, a world leader in technology for robotic-assisted vascular interventions. Thanks to which it is positioned as one of the main leaders in the field of robotic vascular interventions and minimally invasive procedures. 

The acquisition is aimed at simplifying the current challenges faced by practitioners in their daily practice, as robotic-assisted minimally invasive procedures can reduce treatment times, increase treatment accuracy, raise levels of standardisation in clinical procedures and ultimately improve clinical outcomes, which represent the strategic focus of the Advanced Therapies business segment. 

At Baker Tilly GDA, we are experts in the sale of companies Shall we talk? 

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?